29 employees
DiaMedica is a biopharmaceutical company that focuses on developing treatments for stroke.
2000
$4M
from 3 investors over 3 rounds
DiaMedica Therapeutics Inc. raised $4M on July 18, 2016
Investors: Fosun Pharma, Hermes Capital Partners and SK Group